RE: Test sales30 Sep 2024 15:26
Because they were at a massive discount to the share price at the time they were originally granted ?
It is also important to remember that if options are priced way above the prevailing share price when it comes to vesting, directors can chose to just let the options lapse at zero cost to them.
21 June 2024 - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company developing precision medicine tests based on the EpiSwitchยฎ 3D genomics platform, announces that it has granted a total of 10,665,020 options over its ordinary shares of 1 pence each ("Ordinary Shares"), to certain Group employees, including 10,150,020 options to Chief Executive Officer, Dr Jon Burrows ("the Grant of Options"). The options were granted under the Company's 2016 Employee Share Option Plan with an exercise price of 9p per share.